Drug Regulatory Authority of Pakistan: Organizational Structure, Functions and Future Challenges

Posted 30 March 2017 By Shahid Hussain, RPh, PharmD

placeholder+image This article discusses the development of a more effective pharmaceutical regulatory environment in Pakistan through the establishment of a regulatory agency designed to address current good manufacturing practices and quality management systems for drug production to improve the availability, accessibility and affordability of drugs.

Share this article:

Categories: Drugs, Compliance, Quality, Submission and registration, Features

Tags: DRAP, Drug Regulatory Authority of Pakistan

Regulatory Exchange: Latest Updates From the Community